Gene and protein expressions of bone marrow mesenchymal stem cells in a bone tunnel for tendon-bone healing

Chih Hwa Chen, Shu Wen Whu, Chih Hsiang Chang, Chun I. Su

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Purpose: Bone marrow mesenchymal stem cells (BMSCs) injected around tendon grafts can enhance tendon-bone healing and promote fibrocartilage formation. To understand gene and protein expressions of cells during tendon-bone healing, auto-BMSCs were implanted into a bone tunnel in anterior cruciate ligament reconstruction in a rabbit model. Methods: BMSCs were harvested from New Zealand white rabbits. By an anterior cruciate ligament reconstruction model, 1×106 BMSCs in 0.35mL of fibrin glue was injected into bone tunnel as Fibrin-BMSC group. Only fibrin glue (Fibrin group) was injected as control. Three chondrogenesis genes and proteins, including Sox 9, collagen Type II (COII), aggrecan, and three osteogenesis genes and proteins, including Runx2, collagen type I (COI), and osteocalcin, between Fibrin-BMSC and Fibrin group were compared by real-time polymerase chain reaction assay and immunohistochemical assay postoperation. Results: In real-time polymerase chain reaction assay, Sox9, COII, aggrecan, COI, and osteocalcin expressions upregulated and Runx2 downregulated were determined in Fibrin-BMSC group at 1 week. COII, aggrecan upregulated, and Runx2 and osteocalcin downregulated were determined at 4 weeks. In immunohistochemical assay, only Sox9, COII, and aggrecan proteins in only Fibrin-BMSC group were observed at 4 weeks. The protein expression as same as gene expression was obtained in a bone tunnel. Conclusion: Auto-BMSCs promoted COII and aggrecan expression and reduced Runx2 and osteocalcin expression in a bone tunnel. It demonstrated that these cells could enhance fibrocartilage formation because of higher chondrogenesis expression during tendon-bone healing.

Original languageEnglish
Pages (from-to)85-93
Number of pages9
JournalFormosan Journal of Musculoskeletal Disorders
Volume2
Issue number3
DOIs
Publication statusPublished - Aug 2011
Externally publishedYes

Fingerprint

Mesenchymal Stromal Cells
Tendons
Bone Marrow
Aggrecans
Fibrin
Gene Expression
Collagen Type II
Bone and Bones
Osteocalcin
Proteins
Fibrocartilage
Chondrogenesis
Fibrin Tissue Adhesive
Anterior Cruciate Ligament Reconstruction
Collagen Type I
Real-Time Polymerase Chain Reaction
Down-Regulation
Rabbits
Osteogenesis
Transplants

Keywords

  • Bone marrow mesenchymal stem cell
  • Bone tunnel
  • Gene expression
  • Protein expression
  • Tendon-bone healing

ASJC Scopus subject areas

  • Orthopedics and Sports Medicine

Cite this

Gene and protein expressions of bone marrow mesenchymal stem cells in a bone tunnel for tendon-bone healing. / Chen, Chih Hwa; Whu, Shu Wen; Chang, Chih Hsiang; Su, Chun I.

In: Formosan Journal of Musculoskeletal Disorders, Vol. 2, No. 3, 08.2011, p. 85-93.

Research output: Contribution to journalArticle

@article{35b797f39f0b4cadad5c078874b837ca,
title = "Gene and protein expressions of bone marrow mesenchymal stem cells in a bone tunnel for tendon-bone healing",
abstract = "Purpose: Bone marrow mesenchymal stem cells (BMSCs) injected around tendon grafts can enhance tendon-bone healing and promote fibrocartilage formation. To understand gene and protein expressions of cells during tendon-bone healing, auto-BMSCs were implanted into a bone tunnel in anterior cruciate ligament reconstruction in a rabbit model. Methods: BMSCs were harvested from New Zealand white rabbits. By an anterior cruciate ligament reconstruction model, 1×106 BMSCs in 0.35mL of fibrin glue was injected into bone tunnel as Fibrin-BMSC group. Only fibrin glue (Fibrin group) was injected as control. Three chondrogenesis genes and proteins, including Sox 9, collagen Type II (COII), aggrecan, and three osteogenesis genes and proteins, including Runx2, collagen type I (COI), and osteocalcin, between Fibrin-BMSC and Fibrin group were compared by real-time polymerase chain reaction assay and immunohistochemical assay postoperation. Results: In real-time polymerase chain reaction assay, Sox9, COII, aggrecan, COI, and osteocalcin expressions upregulated and Runx2 downregulated were determined in Fibrin-BMSC group at 1 week. COII, aggrecan upregulated, and Runx2 and osteocalcin downregulated were determined at 4 weeks. In immunohistochemical assay, only Sox9, COII, and aggrecan proteins in only Fibrin-BMSC group were observed at 4 weeks. The protein expression as same as gene expression was obtained in a bone tunnel. Conclusion: Auto-BMSCs promoted COII and aggrecan expression and reduced Runx2 and osteocalcin expression in a bone tunnel. It demonstrated that these cells could enhance fibrocartilage formation because of higher chondrogenesis expression during tendon-bone healing.",
keywords = "Bone marrow mesenchymal stem cell, Bone tunnel, Gene expression, Protein expression, Tendon-bone healing",
author = "Chen, {Chih Hwa} and Whu, {Shu Wen} and Chang, {Chih Hsiang} and Su, {Chun I.}",
year = "2011",
month = "8",
doi = "10.1016/j.fjmd.2011.06.002",
language = "English",
volume = "2",
pages = "85--93",
journal = "Formosan Journal of Musculoskeletal Disorders",
issn = "2210-7940",
publisher = "中華民國骨科醫學會",
number = "3",

}

TY - JOUR

T1 - Gene and protein expressions of bone marrow mesenchymal stem cells in a bone tunnel for tendon-bone healing

AU - Chen, Chih Hwa

AU - Whu, Shu Wen

AU - Chang, Chih Hsiang

AU - Su, Chun I.

PY - 2011/8

Y1 - 2011/8

N2 - Purpose: Bone marrow mesenchymal stem cells (BMSCs) injected around tendon grafts can enhance tendon-bone healing and promote fibrocartilage formation. To understand gene and protein expressions of cells during tendon-bone healing, auto-BMSCs were implanted into a bone tunnel in anterior cruciate ligament reconstruction in a rabbit model. Methods: BMSCs were harvested from New Zealand white rabbits. By an anterior cruciate ligament reconstruction model, 1×106 BMSCs in 0.35mL of fibrin glue was injected into bone tunnel as Fibrin-BMSC group. Only fibrin glue (Fibrin group) was injected as control. Three chondrogenesis genes and proteins, including Sox 9, collagen Type II (COII), aggrecan, and three osteogenesis genes and proteins, including Runx2, collagen type I (COI), and osteocalcin, between Fibrin-BMSC and Fibrin group were compared by real-time polymerase chain reaction assay and immunohistochemical assay postoperation. Results: In real-time polymerase chain reaction assay, Sox9, COII, aggrecan, COI, and osteocalcin expressions upregulated and Runx2 downregulated were determined in Fibrin-BMSC group at 1 week. COII, aggrecan upregulated, and Runx2 and osteocalcin downregulated were determined at 4 weeks. In immunohistochemical assay, only Sox9, COII, and aggrecan proteins in only Fibrin-BMSC group were observed at 4 weeks. The protein expression as same as gene expression was obtained in a bone tunnel. Conclusion: Auto-BMSCs promoted COII and aggrecan expression and reduced Runx2 and osteocalcin expression in a bone tunnel. It demonstrated that these cells could enhance fibrocartilage formation because of higher chondrogenesis expression during tendon-bone healing.

AB - Purpose: Bone marrow mesenchymal stem cells (BMSCs) injected around tendon grafts can enhance tendon-bone healing and promote fibrocartilage formation. To understand gene and protein expressions of cells during tendon-bone healing, auto-BMSCs were implanted into a bone tunnel in anterior cruciate ligament reconstruction in a rabbit model. Methods: BMSCs were harvested from New Zealand white rabbits. By an anterior cruciate ligament reconstruction model, 1×106 BMSCs in 0.35mL of fibrin glue was injected into bone tunnel as Fibrin-BMSC group. Only fibrin glue (Fibrin group) was injected as control. Three chondrogenesis genes and proteins, including Sox 9, collagen Type II (COII), aggrecan, and three osteogenesis genes and proteins, including Runx2, collagen type I (COI), and osteocalcin, between Fibrin-BMSC and Fibrin group were compared by real-time polymerase chain reaction assay and immunohistochemical assay postoperation. Results: In real-time polymerase chain reaction assay, Sox9, COII, aggrecan, COI, and osteocalcin expressions upregulated and Runx2 downregulated were determined in Fibrin-BMSC group at 1 week. COII, aggrecan upregulated, and Runx2 and osteocalcin downregulated were determined at 4 weeks. In immunohistochemical assay, only Sox9, COII, and aggrecan proteins in only Fibrin-BMSC group were observed at 4 weeks. The protein expression as same as gene expression was obtained in a bone tunnel. Conclusion: Auto-BMSCs promoted COII and aggrecan expression and reduced Runx2 and osteocalcin expression in a bone tunnel. It demonstrated that these cells could enhance fibrocartilage formation because of higher chondrogenesis expression during tendon-bone healing.

KW - Bone marrow mesenchymal stem cell

KW - Bone tunnel

KW - Gene expression

KW - Protein expression

KW - Tendon-bone healing

UR - http://www.scopus.com/inward/record.url?scp=80051814342&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80051814342&partnerID=8YFLogxK

U2 - 10.1016/j.fjmd.2011.06.002

DO - 10.1016/j.fjmd.2011.06.002

M3 - Article

VL - 2

SP - 85

EP - 93

JO - Formosan Journal of Musculoskeletal Disorders

JF - Formosan Journal of Musculoskeletal Disorders

SN - 2210-7940

IS - 3

ER -